INVESTOR TECHNICAL ASSURANCE

Verify the Technical Milestone Before Releasing the Next Tranche.

Refer a founder who is about to be trusted with somebody else's money.

Trust Before Ship gives investors a bounded evidence record of the identified build, the positive findings located, the obligations that failed or remain unverified, and the limits of the examination.

We do not decide whether a startup will succeed. We help determine whether the supplied software evidence supports the technical milestone being claimed.

INVESTOR DECISION

Does the evidence support releasing more capital?

Release The examined evidence supports the claimed milestone within the stated scope.
Release with conditions Evidence substantially supports the milestone, with named gaps that should become tranche conditions.
Hold The evidence contradicts the claimed milestone in a material way.
Insufficient evidence to decide The evidence available does not permit a conclusion either way.

And when the evidence does not support the milestone, the brief says so— including “insufficient evidence to decide.”

THE DIFFERENCE

They sell findings. We sell a decision-ready evidence record.

Automated tools and specialist reviewers can provide valuable technical evidence. Trust Before Ship applies those evidence sources to a different decision: whether the identified software and declared examination support an investor’s stage-gate assessment.

Typical Technical Evidence

What problems were found?

  • Scanner output
  • Issue counts
  • Technical recommendations
  • Developer-facing detail
  • Possible remediation proposal
THE INVESTOR PROBLEM

A working demonstration is not the same as an evidenced milestone.

AI-assisted development can produce visible progress very quickly. The unresolved question is whether the current software actually supports the milestone described to the investor.

01

Milestone ambiguity

Features may appear complete while critical logic, failure paths or controls remain absent or unverified.

02

Runway exposure

Late defect discovery can require investigation, rework, regression testing and additional verification.

03

Operating-cost exposure

Inefficient model calls, retries, infrastructure and architectural decisions may weaken future economics.

04

Evidence gaps

The investor may not know which build was examined, what was excluded or which claims remain unsupported.

THE CAPITAL-GATE MODEL

A proposed technical-assurance model for four investment checkpoints.

The proposed capital-gate model applies at four possible checkpoints. It is pending investor validation and has not yet been used in an investment engagement.

GATE 01 Initial investment

Is there a real, inspectable software asset behind the pitch?

Establish the identifiable build, supplied scope, technology inventory, major findings and material unknowns.

OUTPUT: TECHNICAL BASELINE
GATE 02 Product milestone

What does the supplied evidence establish about the claimed product milestone?

Compare the stated milestone with the identified build, located findings, failed or unverified obligations, supplied evidence and declared coverage.

OUTPUT: BOUNDED MILESTONE EVIDENCE
GATE 03 Customer readiness

What technical conditions remain before wider commercial exposure?

Identify material trust blockers, unresolved conditions and technical areas that require additional evidence.

OUTPUT: CONDITIONAL READINESS POSITION
GATE 04 Further tranche

Were the required technical conditions met before more capital is released?

Compare the revised build with the original baseline: fixed, still open, newly introduced and unverified.

OUTPUT: TECHNICAL RISK DELTA
WHAT THE INVESTOR RECEIVES

A Capital Release Technical Brief.

We report located, reproducible findings. Absence of a finding is not evidence of absence; areas outside the stated scope are marked unverified, never passed.

A concise investor-facing decision record supported by a deeper evidence register for technical review.

01

Milestone status

Whether the identified build supports the claimed milestone within the declared scope.

02

Critical obligations

Failed, gap and unverified results for the technical obligations agreed for examination, together with any positive evidence that can be stated on a bounded, per-instance basis.

03

Risk concentration

Where the most material security, reliability, maintainability and business-logic risks appear.

04

Indicative remediation exposure

A bounded range for investigation, repair and retesting effort. Trust Before Ship does not perform or quote for the remediation work identified.

05

Unknowns and exclusions

What was not supplied, could not be examined or remains outside the assurance claim.

06

Capital-release conditions

The technical conditions that may need to be met before the next stage or tranche.

EXAMPLE DECISION VIEW

Technical milestone status: release with conditions.

The example below illustrates the format. It is not a rating of any actual startup or investment.

AMBER

Release with conditions

The examination located material findings and failed obligations. Any capital-release decision should account for the stated remediation conditions and the areas that remain unverified.

Examined build COMMIT RECORDED
Claimed milestone NOT FULLY ESTABLISHED
Critical obligations 2 FAILED · 6 UNVERIFIED
Material security finding 1 HIGH FINDING LOCATED
Indicative remediation exposure 8–15 engineering days
Rebuild requirement NOT DETERMINED
Illustrative conditions before tranche balance: address the high-severity finding, supply evidence that the two failed obligations have been corrected, reconcile the deployed build and complete a delta review. Illustrative investor format based on anonymised prior technical evidence. It does not describe an actual investment engagement and is not an investment recommendation.
CLEAR BOUNDARIES

Technical risk is only one part of an investment decision.

Trust Before Ship does not assess the full viability of the company and does not recommend whether an investor should invest.

Outside our purview

  • Market demand
  • Founder or team capability
  • Valuation
  • Governance
  • Legal or regulatory position
  • Sales execution
  • Ultimate commercial outcome

What we help manage

  • Whether the examined build is identifiable
  • Whether the technical milestone is evidenced
  • Whether critical obligations were tested
  • Where material findings are concentrated
  • What remains unverified
  • Whether remediation changed the result
!
INDEPENDENCE MATTERS

We do not profit from the remediation work identified by the audit.

Trust Before Ship does not perform or quote for the remediation work it identifies. That preserves independence — we have nothing to gain from the length of the list — and it deliberately gives up repair revenue.

WHO THIS IS FOR

For capital providers with software risk inside the investment.

Angel investors

Independent technical evidence to support investment review and portfolio conversations.

Venture funds

A consistent evidence layer across investment and portfolio-review checkpoints.

Accelerators

Cohort or milestone assurance before demo day, follow-on introductions or programme completion.

Venture studios

Technical stage-gate evidence across internally developed or externally built applications.

PRIVATE INVESTOR CONVERSATION

Discuss a portfolio company approaching a technical milestone.

No code or confidential investment material is required for the first conversation. We begin by clarifying the milestone, decision, available evidence and appropriate review boundary.

Confidential · Read-only by default · Scope agreed first · Limits declared
PRIVATE INVESTOR ENQUIRY

Tell us about the technical decision you are preparing for.

No source code, confidential investment documents or portfolio-company credentials are required at this stage. We begin by clarifying the milestone, decision and appropriate evidence boundary.

QUICK REFERRAL

Just want to refer someone?

Two fields: your name, and who we should speak to. We will take it from there.

Submitting this form does not create an assurance engagement. Scope, access, confidentiality, evidence limits and commercial terms are agreed separately.